Cargando…
Formulation and Optimization of Avanafil Biodegradable Polymeric Nanoparticles: A Single-Dose Clinical Pharmacokinetic Evaluation
Avanafil (AVA) is a second-generation phosphodiesterase-5 (PDE5) inhibitor. AVA shows high selectivity to penile tissues and fast absorption, but has a bioavailability of about 36%. The aim was to formulate and optimize AVA-biodegradable nanoparticles (NPs) to enhance AVA bioavailability. To assess...
Autores principales: | Aldawsari, Hibah M., Fahmy, Usama A., Abd-Allah, Fathy, Ahmed, Osama A. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356025/ https://www.ncbi.nlm.nih.gov/pubmed/32604853 http://dx.doi.org/10.3390/pharmaceutics12060596 |
Ejemplares similares
-
Formulation Design, Statistical Optimization, and In Vitro Evaluation of a Naringenin Nanoemulsion to Enhance Apoptotic Activity in A549 Lung Cancer Cells
por: Md, Shadab, et al.
Publicado: (2020) -
Avanafil for erectile dysfunction
Publicado: (2019) -
Encapsulation of Lovastatin in Zein Nanoparticles Exhibits Enhanced Apoptotic Activity in HepG2 Cells
por: Alhakamy, Nabil A., et al.
Publicado: (2019) -
LC-MS/MS determination of avanafil and its metabolites in rat plasma and brain: pharmacokinetic study after oral administration and transdermal film application
por: Kammoun, Ahmed K., et al.
Publicado: (2020) -
Computer Optimization of Biodegradable Nanoparticles Fabricated by Dispersion Polymerization
por: Akala, Emmanuel O., et al.
Publicado: (2015)